Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

The authors reply

Janz, David R. MD, MSc; Semler, Matthew W. MD, MSc; Rice, Todd W. MD, MSc

doi: 10.1097/CCM.0000000000002270
Online Letters to the Editor

Section of Pulmonary/Critical Care & Allergy/Immunology, Louisiana State University School of Medicine, New Orleans, LA;

Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN

Drs. Janz, Semler, and Rice contributed in drafting and revision of the article. Investigators were supported by a National Heart, Lung, and Blood Institute T32 award (HL087738 09). All authors have completed and submitted the International Committee of Medical Journal Editors Form for Disclosure of Potential Conflicts of Interest. Dr. Janz’s institution received funding from the National Institutes of Health (NIH). He received support for article research from the NIH. Dr. Semler received support for article research from the NIH. Dr. Rice received support for article research from the NIH. He received funding from GlaxoSmithKline, Avisa Pharma, and Cumberland Pharmaceuticals. He reported serving on an advisory board for Avisa Pharma, LLC, as a DSMB member for GlaxoSmithKline PLC, and as Director of Medical Affairs for Cumberland Pharmaceuticals.

Copyright © 2017 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.